Abattis Bioceuticals Corp. (ATTBF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Aug 19, 2025, 4:00 PM EDT
Abattis Bioceuticals Market Cap
Abattis Bioceuticals has a market cap or net worth of $12.85 thousand as of August 20, 2025. Its market cap has increased by 2,600.21% in one year.
Market Cap
12.85K
Enterprise Value
n/a
Revenue
269.58K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 19, 2012, Abattis Bioceuticals's market cap has decreased from 1.46M to 12.85K, a decrease of -99.12%. That is a compound annual growth rate of -30.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 12.85K | 2,600.21% |
| Dec 30, 2024 | 476.00 | - |
| Dec 29, 2023 | 476.00 | - |
| Dec 30, 2022 | 476.00 | - |
| Dec 31, 2021 | 476.00 | -99.99% |
| Dec 31, 2020 | 5.95M | 177.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.45M |
| Glass House Brands | 554.44M |
| Nika Pharmaceuticals | 453.04M |
| CytoDyn | 363.56M |
| Northwest Biotherapeutics | 355.76M |
| American Oncology Network | 355.44M |